Value-Based Cardiology

ARTICLES

There are conflicting guidelines regarding when to screen cholesterol levels in young adults. A new study aims to clarify at what age asymptomatic individuals should be screened to calculate their elevated risk of developing atherosclerotic cardiovascular disease.
Zachary Bloomgarden, MD; Robert Gabbay, MD, PhD, FACP; Silvio Inzucchi, MD; Dennis P. Scanlon, PhD; and Kenneth Snow, MD, MBA, compare the results of recent trials that suggest the benefits of glucagon-like peptide-1 receptor agonists, for diabetes, in cardiovascular mortality.
In the opening segment of this AJMC Peer ExchangeTM, moderator Dennis P. Scanlon, PhD, discusses results of the EMPA-REG OUTCOME trial that demonstrated treatment effectiveness in both diabetes and cardiovascular mortality.
Getting smokers to quit smoking sometimes requires medical intervention, such as varenicline and bupropion; however, there have been concerns about the safety of these smoking cessation treatments in smokers with chronic obstructive pulmonary disease.
As CMS developed the Medicare Access and CHIP Reauthorization Act (MACRA) over the past few years, it was responsive to the needs and concerns of clinicians, according to William Borden, MD, FACC, FAHA, associate professor of medicine and director of healthcare delivery transformation at the George Washington University. Still, Borden says there are ways the requirements could be simplified, which would benefit both physicians and patients.

EVENTS

July 25-27, 2015
Vancouver, BC, Canada
August 14-16, 2015
Mackinac Island,MI
Compendia
COPD Compendium
Diabetes Compendium
GI Compendium
Lipids Compendium
MACRA Compendium
Oncology Compendium
Rare Disease Compendium
Reimbursement Compendium
Know Your News
HF Compendium
$AD300x250BB$
$vacMongoViewPlus$